This report provides in-depth analysis of hypertension therapeutics market within the eight major geographies of the US, the top five European countries (the UK, France, Germany, Spain and Italy), Japan and Canada. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis.
Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, India, Australia, and Japan. This high prevalence is a substantial contributor to healthcare costs and a major cause of morbidity. Despite this, awareness of hypertension is low among physicians, patients, and the public alike, leading to poor blood pressure control. Enquiry @ http://www.researchbeam.com/anti-hypertensive-therapeutics-in-asia-pacific-to-2021-increasing-prevalence-of-hypertension-drives-growth-despite-weak-pipeline-market/enquire-about-report
Non-Small Cell Lung Cancer (NSCLC) is the second most common cancer globally, and the most common cause of cancer-related mortality. Such a poor outlook, particularly for patients with advanced disease, has created a pressing need for improved therapeutic options. The NSCLC market is undergoing a gradual change from a focus on generic chemotherapy regimens to complex treatment landscape based on different NSCLC subtypes and the presence of various molecular aberrations. Enquiry @ http://www.researchbeam.com/non-small-cell-lung-cancer-therapeutics-in-major-developed-to-2021-emergence-of-immunotherapies-drives-growth-and-creates-a-competitive-second-line-market/enquire-about-report
The 'Global and Chinese Type 2 Diabetes Mellitus Therapeutics Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Type 2 Diabetes Mellitus Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Type 2 Diabetes Mellitus Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
Gamma Therapeutics, Inc. (Gamma Therapeutics), an early stage biotechnology company. It focuses on developing solutions for cardiovascular disease risk assessment, surgical therapy and combat casualty care.
This report studies the global Gonorrhea Therapeutics market, analyzes and researches the Gonorrhea Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Bharat Pharmaceuticals GlaxoSmithKline Pfizer
This report studies Kidney Cancer Diagnostics and Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering GlaxoSmithKline Bayer Pfizer Sanofi S.A Hoffmann La Roche
Big market Research, Otonomy Pipeline Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘Otonomy, Inc. - Product Pipeline Review - 2014’, provides an overview of the Otonomy, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Otonomy, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target.
Exosome Diagnostic and Therapeutics Market: Germany, UK and France to Remain at the Forefront of Demand in the Western Europe Regional Market: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)
Big Market Research, Global Antihypertensives Market Size, Share, Trends, Application, Forecast, Demand, Insights, Analysis, Research, Report, Opportunities,2013 – 2020. Antihypertensives are the drugs that are used to treat high blood pressure. Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Comprehensive coverage of global antihypertensives market along with disease overview, market trends, drivers and restraints would provide key insights to market dynamics.
The new mRNA Vaccine And Therapeutics Market report offers a comprehensive study of the present scenario of the market coupled with major market dynamic. Also, it highlights the in-depth market analysis with the latest trends, drivers and its segments with respect to regional and country. Further, this report profiles top key players of the mRNA vaccine And therapeutics and analyze their market share, strategic development and other development across the globe.
Big Market Research, Pyelonephritis therapeutic pipeline market, Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis. Global Markets Direct’s, ‘Pyelonephritis - Pipeline Review, H2 2014’, provides an overview of the Pyelonephritis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pyelonephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target.
Big Market Research, Bone Degeneration therapeutic pipeline market, Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis. Global Markets Direct’s, ‘Bone Degeneration - Pipeline Review, H2 2014’, provides an overview of the Bone Degeneration’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Bone Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target.
Big Market Research, Liposarcoma Therapeutic Market, Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H2 2014’, provides an overview of the Liposarcoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Liposarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target.
Big Market Research, Swine Influenza therapeutic pipeline market, Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis.Global Markets Direct’s, ‘Swine Influenza - Pipeline Review, H2 2014’, provides an overview of the Swine Influenza’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Swine Influenza, complete with comparative analysis at various stages, therapeutics assessment by drug target.
Big Market Research, Mumps therapeutic pipeline market, Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis. Global Markets Direct’s, ‘Mumps - Pipeline Review, H2 2014’, provides an overview of the Mumps’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mumps, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Big Market Research, Nocturia therapeutic pipeline Market Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis. Global Markets Direct’s, ‘Nocturia - Pipeline Review, H2 2014’, provides an overview of the Nocturia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nocturia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Big Market Research, Myocarditis Therapeutic Pipeline Market, Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘Myocarditis - Pipeline Review, H2 2014’, provides an overview of the Myocarditis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocarditis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Bone Therapeutics SA - Product Pipeline Review - 2014, provides an overview of the Bone Therapeutics SAs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Bone Therapeutics SAs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. See Full Report : http://bit.ly/1AEyjSo
Welcome to Mohammad Akhter Hussain Director, Marketing One of the finest infrastructure and facilities found anywhere in the World Fully automated with (IBMS) of USA ...
The NSCLC market in the APAC region is estimated to have been worth $1.8 billion in 2012 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.3% to reach $2.9 billion by 2019. Detailed report at: http://www.reportsandintelligence.com/nsclc-therapeutics-in-asia-pacific-to-2019-personalized-therapies-focus-on-untapped-segment-of-squamous-cell-carcinoma-to-expand-treatment-pool-market
Diuretic drugs also termed as ‘water pills’ assists the kidneys eliminate extra water and concentration of sodium and chloride from the body by increasing flow of urine. Diuretic drugs are prescribed as first line drugs used solely as therapeutic agents to treat hypertension while combination with other antihypertensive drugs is used in treatment of more severe forms of hypertension. Diuretics are extensively used in treatment for people facing health concerns like hyper tension, water retention problems, liver disorders, cardiovascular diseases as well as nephrological and urological disorders.
Sickle-cell Anemia Therapeutics Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the Sickle-cell Anemia Therapeutics market landscape in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Single User License: US $2500; Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=323205.
US has 2 separate processes (incentive and requirement) that are only partially unified. Europe's pediatric process is unified under their legislation. ...
EMEA coordinates the existing scientific resources of Member States ... EMEA's centralized process coordinates the assessment by representatives from the member states ...
How Will the Metabolic Syndrome Impact Different Segments of the ... (diethylpropion, phentermine, phendimetrazine, mazindol, sibutramine, and orlistat) ...
FASTER DEVELOPMENT OF SPECIALTIES ... for faster development in Specialties ... world economy even though the first signs of recovery start to be noticeable for ...
to be a less cyclical company in the current economic uncertainty ... Canada for the treatment of symptomatic gastro-esophageal reflux disease (GERD) ...
Title: PowerPoint Presentation Author: MB Last modified by: tichym Created Date: 11/10/2003 5:50:58 PM Document presentation format: p edv d n na obrazovce
raise awareness in health professionals, consumers and policy makers ... regional training courses in use of drug utilization metrics and their application ...
Practice guidelines aim to guide physician practice according to the best available evidence ... Physician-reported data on new and continuing medications for ...
I. Pharmacy and the Health Care System ... 36% more than one pharmacy. 26% skipped taking meds ... Contracts out for pharmacy service and all other providers ...
... and other related technologies Developmental trajectory Differences/disparities across populations Epigenetics /meta-genomics Functional status Global health ...
Managing Risk in Early Drug Development Vice President, Drug Development Programs YalePharma 10 Year Trends in US Biomedical Research Spending Some Excuses for Poor ...
Inhibition of ACE leads to decreased systemic arteriolar resistance and mean ... from fragrant grains are fragrant noodles, biscuits, cakes, breads, popcorn, ...
Sequencing will cease as of this time and all 'draft' sequence will have been ... Sequencers will move on to finish mouse, rat, honeybee, chicken, and chimpanzee ...
... organisms, but these are mainly flies, worms, or fish ... Need to know the structure of the target usually obtained through X-ray crystallography or NMR ...
Discover why India is the best choice for importing pharmaceuticals to Ethiopia. Explore top Indian pharmaceutical companies like Aliyan Pharmaceuticals.
AHRQ Review-- Evidence for Tx of Clinically Localized Prostate Cancer. Limited evidence on relative safety and effectiveness associated with major treatment options ...
Voluntary Step and Cognitive Task 66 healthy elderly vs. healthy young adults Tested voluntary stepping on force plate ... Up and Go Developed by ... Diabetes ...
The Organic Chemistry of Drug Design and Drug Action Chapter 5 Enzyme Inhibition and Inactivation Enzyme Inhibition and Inactivation Categories of Enzyme Inhibitors ...
Chapter 13. Drug Design and Discovery Drug Discovery Clinical Trials Drug Discovery Drug Discovery Without a Lead Lead Discovery High-throughput Screens (HTS) Lead ...
Thickening and hardening of ... Fatty streaks develop along the intima (innermost layer ... macrophages and increasing intravascular tone and coagulability ...
Discussion Questions What to Do About High Drug Costs What can you as a pharmacist do to help your patients? What can our institution do to better control costs?
Global Injectable Drug Delivery Market report available @ http://www.reportsnreports.com/reports/758272-global-injectable-drug-delivery-market-by-manufacturers-regions-type-and-application-forecast-to-2021.html . The report has been divided into key manufacturers regionally and also covered few of the other market sectors. It has also mentioned market opportunities, market risk, and market driving force.
Health Care Spending as a Share of U.S. Economic Output Has Been ... Health care spending as a ... Reducing caloric intake of animals by 30% increases life ...
Out-of-pocket spending as a percentage of all personal health. care spending ... Health insurance costs per year. Workers in California Pay About 25 Percent ...
The value of the hypertension market in the major developed markets amounted to an estimated $40.0 billion in 2013 and is expected to decline during the forecast period at a negative Compound Annual Growth Rate (CAGR) of 0.9% to $37.6 billion in 2020, with growth expected from 2013 to 2017 at a CAGR of 2.6% and a decline thereafter. Detailed report at: http://www.reportsandintelligence.com/antihypertensive-therapeutics-in-major-developed-to-2020-increased-uptake-of-combination-therapies-to-offset-effects-of-key-patent-expiries-market